Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma (GUIDANCE006)
cCR following PD-1 inhibitor-based combination therapy is associated with excellent survival in patients with unresectable HCC. Such response and the clinical characteristics that predict it may be useful for assessing prognosis after combination therapy.
Authors
- Li-Xin Pan (ORCID: https://orcid.org/0000-0002-3491-5095)
- Shuchang Chen (ORCID: https://orcid.org/0000-0001-8374-2672)
- Hongbing Yao (ORCID: https://orcid.org/0000-0002-9177-1251)
- Yongrong Lai (ORCID: https://orcid.org/0000-0002-0371-1719)
- Qingqing Pang
- Yong-Rong Liang
- Xueyao Wang (ORCID: https://orcid.org/0009-0009-9386-0088)
- Ming-Song Wu (ORCID: https://orcid.org/0000-0001-8513-0637)
- Dalong Yang (ORCID: https://orcid.org/0000-0003-0090-2277)
- Yihe Yan (ORCID: https://orcid.org/0000-0002-3387-2273)
- Jingying Nong (ORCID: https://orcid.org/0000-0002-0682-2190)
- Ze Su (ORCID: https://orcid.org/0009-0000-1360-0783)
- Fan-Jian Zeng
- Jian‐Hong Zhong (ORCID: https://orcid.org/0000-0002-1494-6396)
- Fu-Xin Li
- Ning Peng (ORCID: https://orcid.org/0000-0003-4213-1159)
- Mian-Jing Li
- Wenfeng Li (ORCID: https://orcid.org/0000-0002-3250-3062)
- Fuquan Yang (ORCID: https://orcid.org/0000-0002-2841-5342)
- Shaoping Liu
- Chuang Qin (ORCID: https://orcid.org/0000-0002-7296-914X)
- Teng-Meng Zhong
- Zhen Liu (ORCID: https://orcid.org/0000-0002-2080-7288)
- Min Luo (ORCID: https://orcid.org/0009-0001-1101-1675)
- Kang Chen (ORCID: https://orcid.org/0000-0003-0745-7946)
- Guodong Wang (ORCID: https://orcid.org/0000-0003-0398-6373)
- Jie Liu (ORCID: https://orcid.org/0000-0002-0373-2827)
- Xiao-Feng Dong
- Yaqun Yu (ORCID: https://orcid.org/0009-0006-8664-5548)
- Zhicheng Li (ORCID: https://orcid.org/0000-0003-4140-0580)
- Liang Ma
- Lin Ye
- Yongyu Yang (ORCID: https://orcid.org/0000-0001-6239-9262)
- Pingping Guo (ORCID: https://orcid.org/0000-0002-0371-1460)
- Pei‐Sheng Wu
- Sicong Lu
Institutions
- Guangxi Medical University (CN)
- Hengshui University (CN)
- Guilin Medical University (CN)
- Beihai People's Hospital (CN)
- Liuzhou Maternal and Child Health Hospital (CN)
- Liuzhou General Hospital (CN)
- Beibu Gulf University (CN)
- The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine (CN)
- Wuzhou University (CN)
- The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
- First Affiliated Hospital of GuangXi Medical University (CN)
- The Second Nanning People's Hospital (CN)
- Baise University (CN)
- Affiliated Hospital of Guilin Medical College (CN)
- First People's Hospital of Nanning (CN)
- Hezhou University (CN)
- Wuzhou Red Cross Hospital (CN)
- Yulin University (CN)
Publication Details
- Journal
- Liver Cancer
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1159/000549844
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Guangxi Medical University
- Guangxi Key Research and Development Program
- Division of Graduate Education